SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027969
Filing Date
2016-11-07
Accepted
2016-11-07 16:31:19
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20160930.htm 10-Q 1397174
2 EX-10.1 flxn-ex101_16.htm EX-10.1 24235
3 EX-31.1 flxn-ex311_7.htm EX-31.1 10142
4 EX-31.2 flxn-ex312_11.htm EX-31.2 11056
5 EX-32.1 flxn-ex321_8.htm EX-32.1 6656
6 EX-32.2 flxn-ex322_10.htm EX-32.2 6762
  Complete submission text file 0001564590-16-027969.txt   4797803

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT flxn-20160930.xml EX-101.INS 959758
8 XBRL TAXONOMY EXTENSION SCHEMA flxn-20160930.xsd EX-101.SCH 36288
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20160930_cal.xml EX-101.CAL 46961
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20160930_def.xml EX-101.DEF 76917
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20160930_lab.xml EX-101.LAB 276904
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20160930_pre.xml EX-101.PRE 209828
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 161978526
SIC: 2834 Pharmaceutical Preparations